Fierce Virtual Series: JPM Week 2021 has ended
Back To Schedule
Tuesday, January 12 • 1:00pm - 1:30pm
Manufacturing innovation across new modalities

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
The successful outcomes delivered by cell and gene therapies coupled with emergence of modalities across nucleic acid therapeutics and microbiomes pose the next challenge for innovators to make these new modalities available at scale. Faster adoption of emerging cutting-edge development and manufacturing technologies will be vital to success and broad accessibility for patients. In this talk, we review and present key areas of technology innovation that have the potential to reshape how these advanced therapeutics are manufactured at scale.

avatar for Julien Meissonnier

Julien Meissonnier

Vice President & Chief Scientific Officer, Catalent
Julien Meissonnier is part of Catalent’s executive leadership team heading up the company’s scientific community and customer advisory partnerships helping to improve formulation and adoption of new drug delivery technologies. He leads new product development and technology... Read More →

Tuesday January 12, 2021 1:00pm - 1:30pm EST